Camron D. Bryant

Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo

Daniel J. Apicco, Peter E.A. Ash, Brandon F. Maziuk et al. · Nature Neuroscience · 2017 · 267 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Degenerative Pathology +9

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

Kabirullah Lutfy, Shoshana Eitan, Camron D. Bryant et al. · PubMed · 2003 · 220 citations

Pain Medicine, Molecular Pain, Orl-1 Receptor Antagonist +19

Behavioral Differences among C57BL/6 Substrains: Implications for Transgenic and Knockout Studies

Camron D. Bryant, Nanci N. Zhang, Greta Sokoloff et al. · Journal of Neurogenetics · 2008 · 218 citations · Full text

Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors

Kabirullah Lutfy, Shoshana Eitan, Camron D. Bryant et al. · Journal of Neuroscience · 2003 · 213 citations · Full text

Pain Disorders, Pain Medicine, Molecular Pain +20

The blessings and curses of C57BL/6 substrains in mouse genetic studies

Camron D. Bryant · Annals of the New York Academy of Sciences · 2011 · 128 citations · Full text

Genetics, Genetic Epidemiology, Genomic Mechanism +20